$22.75
+0.90 (+4.12%)
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
-43.7% upside
Low Target
$8.80
Average Target
$12.80
High Target
$18.52
Current Price
$22.75
Current
$22.75
$22.75
Target
$12.80
$12.80
$8.80
$12.80 avg
$18.52
Scenario Analysis
Bear Case
$8.80
-61.3%
Low target
Base Case
$12.80
-43.7%
Avg target
Bull Case
$18.52
+-18.6%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$31.18
-27.0% from high
52-Week Low
$1.92
+1,084.9% from low
Target vs 52W High
$12.80
-58.9% vs high
Next Earnings Report
Mar 26, 2026 · After Market Close
Today
EPS Est: $-1.05
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 69% | $257.58 | +24.3% |
| AMGN | Hold | 42 | 50% | $190.87 | -46.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.3% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | -3.7% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -89.8% |
| ALNY | Strong Buy | 36 | 78% | $102.31 | -68.9% |
| INSM | Strong Buy | 26 | 92% | $143.40 | -3.3% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -27.6% |